P

Inventor

AKKARI RHALID

FR12 patents
⚠️ This page may combine multiple inventors who share the name “AKKARI RHALID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ABBVIE SARL

4 patents
US10259810B2Apr 16, 2019

N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use

ABBVIE SARL5 citations82
US9890158B2Feb 13, 2018

N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use

ABBVIE SARL5 citations81
US10647717B2May 12, 2020

N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use

ABBVIE SARL1 citations71
US10130622B2Nov 20, 2018

Compounds for treatment of cystic fibrosis

ABBVIE SARL0 citations37

ASTEX THERAPEUTICS LTD

3 patents
US9464071B2Oct 11, 2016

Pyrazolyl quinoxaline kinase inhibitors

ASTEX THERAPEUTICS LTD24 citations93
US9850228B2Dec 26, 2017

Pyrazolyl quinoxaline kinase inhibitors

ASTEX THERAPEUTICS LTD17 citations91
US10519137B2Dec 31, 2019

Pyrazolyl quinoxaline kinase inhibitors

ASTEX THERAPEUTICS LTD6 citations83

SAXTY GORDON

2 patents
US8895601B2Nov 25, 2014

Pyrazolyl quinoxaline kinase inhibitors

SAXTY GORDON25 citations91
US8481531B2Jul 9, 2013

Bicyclic heterocyclyl derivatives as FGFR kinase inhibitors for therapeutic use

SAXTY GORDON9 citations82

UNIV BONN

1 patent
US8623593B1Jan 7, 2014

GPR 17 agonists and screening assay

UNIV BONN10 citations75

ABBVIE S ÀR L

1 patent
US9796711B2Oct 24, 2017

Substituted pyrazolo[3,4-b]pyridin-6-carboxylic acids and method of use

ABBVIE S ÀR L2 citations59

KOSTENIS EVI

1 patent
US8404436B1Mar 26, 2013

Methods of identifying modulators of GPR17

KOSTENIS EVI0 citations38